BRPI0408826A - derivados de oxazol, sua fabricação e uso como agentes farmacêuticos - Google Patents

derivados de oxazol, sua fabricação e uso como agentes farmacêuticos

Info

Publication number
BRPI0408826A
BRPI0408826A BRPI0408826-3A BRPI0408826A BRPI0408826A BR PI0408826 A BRPI0408826 A BR PI0408826A BR PI0408826 A BRPI0408826 A BR PI0408826A BR PI0408826 A BRPI0408826 A BR PI0408826A
Authority
BR
Brazil
Prior art keywords
manufacture
pharmaceutical agents
oxazole derivatives
compounds
derivatives
Prior art date
Application number
BRPI0408826-3A
Other languages
English (en)
Inventor
Birgit Bossenmaier
Walter Gunar Friebe
Thomas Friess
Bernhard Goller
Matthias Rueth
Edgar Voss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0408826A publication Critical patent/BRPI0408826A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"DERIVADOS DE OXAZOL, SUA FABRICAçãO E USO COMO AGENTES FARMACêUTICOS". A presente invenção refere-se aos compostos da fórmula geral (I), os seus sais farmaceuticamente aceitáveis, formas enancioméricas, diastereoisómeros e racematos, a preparação dos compostos acima mencionados medicamentos que contenham os mesmos e a sua fabricação, bem como o uso dos compostos acima mencionados para o controle ou a prevenção de doenças tais como o câncer.
BRPI0408826-3A 2003-03-28 2004-03-26 derivados de oxazol, sua fabricação e uso como agentes farmacêuticos BRPI0408826A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03007124 2003-03-28
US45974103P 2003-04-02 2003-04-02
PCT/EP2004/003205 WO2004085434A1 (en) 2003-03-28 2004-03-26 Novel oxazole derivatives, their manufacture and use as pharmaceutical agents

Publications (1)

Publication Number Publication Date
BRPI0408826A true BRPI0408826A (pt) 2006-04-04

Family

ID=36748274

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408826-3A BRPI0408826A (pt) 2003-03-28 2004-03-26 derivados de oxazol, sua fabricação e uso como agentes farmacêuticos

Country Status (18)

Country Link
US (1) US7205325B2 (pt)
EP (1) EP1613623A1 (pt)
JP (1) JP2006515019A (pt)
KR (1) KR100842692B1 (pt)
CN (1) CN100386325C (pt)
AR (1) AR043920A1 (pt)
AU (1) AU2004224173A1 (pt)
BR (1) BRPI0408826A (pt)
CA (1) CA2519053A1 (pt)
CL (1) CL2004000630A1 (pt)
CO (1) CO5611130A2 (pt)
HR (1) HRP20050831A2 (pt)
MX (1) MXPA05010135A (pt)
NO (1) NO20054360L (pt)
RU (1) RU2005133073A (pt)
TW (1) TW200505913A (pt)
WO (1) WO2004085434A1 (pt)
ZA (1) ZA200506953B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005526B2 (en) * 2004-05-25 2006-02-28 Hoffmann-La Roche Inc. Thioether derivatives
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
US7429605B2 (en) * 2005-08-04 2008-09-30 Hoffmann-La Roche Inc. Phenylpyridine derivatives
EP1915370A1 (en) * 2005-08-08 2008-04-30 F.Hoffmann-La Roche Ag Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
PL1954684T3 (pl) 2005-11-15 2014-10-31 Otsuka Pharma Co Ltd Związek oksazolowy i kompozycja farmaceutyczna
CA2995617A1 (en) * 2017-11-03 2019-05-03 Universite De Montreal Heterocyclic mitochondrial activity inhibitors and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK531479A (da) 1979-01-19 1980-07-20 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
GR71915B (pt) 1979-11-27 1983-08-16 Pfizer
DE3808283A1 (de) 1988-03-12 1989-09-21 Boehringer Ingelheim Kg Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung
US5359078A (en) 1989-05-19 1994-10-25 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
US5281593A (en) 1990-07-31 1994-01-25 Lilly Industries Limited Certain indole derivatives useful as leukotriene antagonists
GB9122590D0 (en) 1991-10-24 1991-12-04 Lilly Industries Ltd Pharmaceutical compounds
US5322847A (en) 1992-11-05 1994-06-21 Pfizer Inc. Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
EP0754683B1 (en) 1994-04-08 2002-08-14 Sumitomo Chemical Company Limited Ether compound, use thereof, and intermediate for producing the compound
US5883106A (en) 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
JPH09136877A (ja) 1995-06-16 1997-05-27 Takeda Chem Ind Ltd 複素環化合物、その製造法及び用途
DE19610882A1 (de) 1996-03-20 1997-09-25 Dresden Arzneimittel Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6211215B1 (en) 1996-07-19 2001-04-03 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
DE69722258T2 (de) 1996-10-07 2004-03-18 Eli Lilly And Co., Indianapolis Neue verbindungen nutlich als neuroschützende mittel
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
EP1439178A4 (en) 2001-10-05 2005-11-16 Takeda Pharmaceutical Heterocyclic compounds, oxazole derivatives, process for their preparation and their use
WO2003059907A1 (en) 2002-01-17 2003-07-24 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof

Also Published As

Publication number Publication date
CA2519053A1 (en) 2004-10-07
US7205325B2 (en) 2007-04-17
CO5611130A2 (es) 2006-02-28
TW200505913A (en) 2005-02-16
CL2004000630A1 (es) 2005-02-04
KR20050118688A (ko) 2005-12-19
JP2006515019A (ja) 2006-05-18
AU2004224173A1 (en) 2004-10-07
EP1613623A1 (en) 2006-01-11
KR100842692B1 (ko) 2008-07-01
HRP20050831A2 (en) 2006-09-30
CN100386325C (zh) 2008-05-07
CN1764660A (zh) 2006-04-26
AR043920A1 (es) 2005-08-17
WO2004085434A1 (en) 2004-10-07
NO20054360L (no) 2005-10-11
MXPA05010135A (es) 2005-11-16
ZA200506953B (en) 2006-05-31
US20040209933A1 (en) 2004-10-21
RU2005133073A (ru) 2006-06-10

Similar Documents

Publication Publication Date Title
BRPI0519567A2 (pt) heterociclos tricÍclicos, sua fabricaÇço e uso como agentes farmacÊuticos
BRPI0608178A2 (pt) derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos
BRPI0409182A (pt) derivados de oxima e seu uso como agentes farmaceuticamente ativos
BR0316081A (pt) Derivados de 2-piridona como inibidores de elastase de neutrófilo
BRPI0407618A (pt) derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização
BRPI0517803A (pt) pirazolpirimidinas 1,4-substituìdas como inibidores de cinase
BR0116063A (pt) Inibidores de sulfonamida heterocìclica da produção de beta amilóide e seus usos
BRPI0508570A (pt) composto, composição farmacêutica, e, uso da mesma
BRPI0515885A (pt) derivados de ftalazinona, sua preparação e uso como agentes farmacêuticos
NO20082643L (no) Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft
BR0210874A (pt) Derivados de tiazol-benzamida e composições farmacêuticas para a inibição da proliferação celular e métodos para o seu uso
BRPI0414570A (pt) derivados de 2-piridona como inibidores de elastase de neutrófilo e seu uso
BRPI0410760A (pt) compostos, processo para fabricação dos mesmos, composições farmacêuticas e uso deste compostos
ATE327225T1 (de) Neue verwendung von benzothiazolderivaten
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
BRPI0512330A (pt) derivados de pirazol-pirimidina
BRPI0111142B8 (pt) utilização de derivados de biguanida ou sais farmaceuticamente aceitáveis dos mesmos para fabricação de medicamento tendo um efeito cicatrizante
BRPI0417714A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0508485A (pt) compostos de pentafluorsulfanila, sua fabricação e uso como agentes farmacêuticos
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
BRPI0411246A (pt) composto, uso do mesmo, composição farmacêutica, e, métodos para terapia contra dor em um animal de sangue quente e para a preparação de um composto
BRPI0408826A (pt) derivados de oxazol, sua fabricação e uso como agentes farmacêuticos
BR0315106A (pt) Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica
BR0318659A (pt) derivados de prolina usados como ingredientes farmacêuticos ativos no tratamento de tumores

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2137 DE 20/12/2011.